Antabio Is A Clinical Stage Biopharmaceutical Company Based In Labegefrancefounded In 2009The Company Focuses On Developing Novel Antibacterial Resistance Breakers To Address Drug Resistant Pathogens Identified As Critical Priorities By The World Health Organizationantabio S Primary Product Development Involves Stand Alone Inhibitors Of Bacterial Metalloenzymeswhich Are Designed To Enhance The Effectiveness Of Antibiotics Against Serious Infections One Of Antabio S Key Advancements Is The Completion Of A Phase 1 Clinical Study For Mem Ant3310Aimed At Treating Severe Hospital Infectionsthe Company Has Also Filed Several Patents Related To Antibiotics And Bacterial Disease Treatmentswith A Strong Commitment To Combating Antimicrobial Resistanceantabio Is Actively Engaged In Fundraising Effortshaving Raised A Total Of $62 45 Million As Of Early 2025Which Supports Its Ongoing Clinical Developments
| Company Name | Antabio Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States